Virus-like particle and DNA-based candidate AIDS vaccines

Vaccine. 2003 Jan 30;21(7-8):638-43. doi: 10.1016/s0264-410x(02)00572-8.

Abstract

Both humoral and cellular immune responses are critical for the control of HIV infection and replication. We have established systems for production of HIV and SIV virus-like particles containing high levels of viral Env proteins using the baculovirus expression system. Evaluation of immunogenicity showed that immunization with virus-like particles induced both cellular and neutralizing antibody responses. Furthermore, mucosal administration of virus-like particles effectively induced both mucosal and systemic immune responses. These results indicate that virus-like particles consisting of HIV structural proteins are an attractive vaccine platform for eliciting anti-viral immune responses, especially neutralizing antibody responses. We have also synthesized codon-optimized genes for HIV Env proteins and evaluated their immunogenicity. Combinations of virus-like particle and DNA-based vaccination are promising for inducing strong cellular and neutralizing antibody responses against HIV.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / immunology*
  • Administration, Intranasal
  • Animals
  • Gene Products, env / genetics
  • Gene Products, env / immunology
  • Gene Products, gag / genetics
  • Gene Products, gag / immunology
  • HIV / genetics
  • HIV / immunology
  • Simian Immunodeficiency Virus / genetics
  • Simian Immunodeficiency Virus / immunology
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / immunology*
  • Virion / immunology

Substances

  • AIDS Vaccines
  • Gene Products, env
  • Gene Products, gag
  • Vaccines, DNA